The Role of Matrix Metalloproteinase 13 and Vitamin D in Osteoarthritis: A Hospital-Based Observational Study.
elisa
kellgren-lawrence stage
knee osteoarthritis
matrix metalloproteinase 13
vitamin d
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
accepted:
18
09
2023
medline:
20
10
2023
pubmed:
20
10
2023
entrez:
20
10
2023
Statut:
epublish
Résumé
Introduction Osteoarthritis (OA) is the most common form of degenerative joint disease characterized by the progressive degeneration of articular cartilage, osteophyte formation, and joint space narrowing. Matrix metalloproteinases (MMPs) are potential biomarkers for osteoarthritis. Aims and objective The study's aim is the estimation of serum and synovial fluid matrix metalloproteinase (MMP) 13 and serum vitamin D levels in the grade 3 and grade 4 stages of osteoarthritis according to the Kellgren and Lawrence (KL) system of classification. Materials and methods A total of 100 subjects were included; of them, 25 patients with grade 3 and 25 patients with grade 4 knee osteoarthritis diagnosed clinically and radiologically according to the Kellgren and Lawrence criteria have been enrolled in the study, and 50 patients with knee pain having a diagnosis other than degenerative OA of the knee were taken as controls. Venous blood and synovial fluid have been collected from all of them for the estimation of MMP-13 and vitamin D. The enzyme-linked immunosorbent assay (ELISA) and chemiluminescent microparticle immunoassay (CMIA) methods were used for the estimation of MMP-13 and vitamin D, respectively. Results The mean value of synovial fluid MMP-13 was found to be elevated in grade 4 as compared to grade 3 and the control group, whereas the mean value of serum MMP-13 was found to be elevated in grade 3 as compared to grade 4 and control. The level of serum vitamin D was found deficient in OA patients as compared to control. The Kruskal-Wallis test was performed to compare these groups, and there was a significant difference between these groups (p-value of <0.05). Summary and conclusion High synovial and serum MMP-13 is associated with knee structural abnormalities in patients with knee OA as compared to the control group suggesting that MMP-13 can be a biomarker in knee OA, whereas the decreased level of vitamin D may be associated with an increased risk for the progression of OA; hence, serum vitamin D may be a good indicator for the prediction of the initiation of OA.
Identifiants
pubmed: 37859901
doi: 10.7759/cureus.45437
pmc: PMC10582788
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e45437Informations de copyright
Copyright © 2023, Kumar et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Bioorg Med Chem. 2007 Mar 15;15(6):2223-68
pubmed: 17275314
Int J Mol Sci. 2021 Feb 09;22(4):
pubmed: 33572320
J Leukoc Biol. 2007 Dec;82(6):1375-81
pubmed: 17709402
J Clin Invest. 1996 Feb 1;97(3):761-8
pubmed: 8609233
Nat Rev Dis Primers. 2016 Oct 13;2:16072
pubmed: 27734845
Arthritis Rheum. 2000 Sep;43(9):1916-26
pubmed: 11014341
Osteoarthritis Cartilage. 2002 Aug;10(8):611-6
pubmed: 12479382
Rheumatology (Oxford). 2003 Nov;42(11):1311-6
pubmed: 12867590
Acta Orthop Traumatol Turc. 2016;50(3):356-61
pubmed: 27130394
Br Med Bull. 2013;105:185-99
pubmed: 23337796
Curr Opin Rheumatol. 2015 May;27(3):289-94
pubmed: 25784380
PM R. 2011 Jun;3(6 Suppl 1):S3-11
pubmed: 21703577
Cell Mol Life Sci. 2000 Jan 20;57(1):5-15
pubmed: 10949577
J Bone Joint Surg Am. 2003 Dec;85(12):2371-7
pubmed: 14668507
J Med Life. 2014 Mar 15;7(1):37-41
pubmed: 24653755
Exp Ther Med. 2014 Aug;8(2):391-394
pubmed: 25009588
Curr Rheumatol Rev. 2017;13(1):65-71
pubmed: 27041085
Arthritis Rheum. 1999 May;42(5):854-60
pubmed: 10323440